TWO · 1780.TWO
Allied Biotech Corporation
NT$23.95-NT$0.10 (-0.42%)
Allied Biotech Corporation’s quoted price sits in the lower half of its reported 52-week range, 35.01% below the high.
Loading market information…
TWO · 6857.TWO · TWD
Stock price
Quote as of Oct 29, 2026, 01:34 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Acer Medical Inc.’s quoted price sits in the lower half of its reported 52-week range, 29.3% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Acer Medical Inc. is a company dedicated to the healthcare industry, providing advanced solutions that incorporate artificial intelligence, clinical data analysis, and specialized software. Their product lineup features VeriSee DR, an AI-powered diagnostic tool for detecting diabetic retinopathy; VeriSee AMD, an AI-enabled screening application focused on identifying age-related macular degeneration; and VeriOsteo OP, an AI-assisted screening software used to detect anomalies in bone mineral density. The company was established in 2018 and is headquartered in New Taipei City, Taiwan.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:10 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$23.95-NT$0.10 (-0.42%)
Allied Biotech Corporation’s quoted price sits in the lower half of its reported 52-week range, 35.01% below the high.
NT$29.45NT$0.00 (0.0%)
Genomics BioSci & Tech. Co.,Ltd.’s quoted price sits in the upper half of its reported 52-week range, 20.08% below the high.
NT$16.80-NT$0.25 (-1.47%)
OK Biotech Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 8.75% below the high.
NT$31.45+NT$0.55 (+1.78%)
DIVA Laboratories, Ltd.’s quoted price sits in the lower half of its reported 52-week range, 16.8% below the high.
NT$28.50-NT$0.15 (-0.52%)
Chi Sheng Pharma & Biotech Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 7.92% below the high.
NT$17.60-NT$0.10 (-0.56%)
Arich Enterprise Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.67% below the high.
NT$9.88-NT$0.06 (-0.6%)
InnoPharmax Inc.’s quoted price sits in the lower half of its reported 52-week range, 58.4% below the high.
NT$21.40-NT$0.55 (-2.51%)
Shangya Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 55.69% below the high.
